{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 2741, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de071-46a1-7225-9b14-04fe7f7f59d9", "docSlug": "2120122995ea0e3bcae2e5ba1ee4dadc", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 23 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "go_to_market", "function": "plan_implementation", "notes": "Includes logos of four partner organizations.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-46a1-7225-9b14-04fe7f7f59d9/10", "deckHref": "/decks/019de071-46a1-7225-9b14-04fe7f7f59d9", "deckAnchorHref": "/decks/019de071-46a1-7225-9b14-04fe7f7f59d9#slide-10", "loopMatches": [ { "to": 12, "from": 10, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "81ffe8fb-6e04-4bb2-b668-9b0f1dd6692c", "evidence": "Slides 10-12 present the go-to-market strategy and commercialization plan, highlighting quick wins and big bets", "position": 1, "objective": "What are the quick wins and big bets for ColoAlert's commercialization?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 12, "from": 10, "beatId": "b6ce095a-2569-4613-b6ea-05637d9e9e17", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "Slides 10-12 present the go-to-market strategy and commercialization plan, calling for action", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-46a1-7225-9b14-04fe7f7f59d9", "docSlug": "2120122995ea0e3bcae2e5ba1ee4dadc", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 23 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "go_to_market", "function": "plan_implementation", "notes": "The slide uses a bulleted list to detail the partnership strategy, focusing on leveraging existing lab infrastructure to minimize marketing overhead.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-46a1-7225-9b14-04fe7f7f59d9/11", "deckHref": "/decks/019de071-46a1-7225-9b14-04fe7f7f59d9", "deckAnchorHref": "/decks/019de071-46a1-7225-9b14-04fe7f7f59d9#slide-11", "loopMatches": [ { "to": 12, "from": 10, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "81ffe8fb-6e04-4bb2-b668-9b0f1dd6692c", "evidence": "Slides 10-12 present the go-to-market strategy and commercialization plan, highlighting quick wins and big bets", "position": 1, "objective": "What are the quick wins and big bets for ColoAlert's commercialization?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 12, "from": 10, "beatId": "b6ce095a-2569-4613-b6ea-05637d9e9e17", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "Slides 10-12 present the go-to-market strategy and commercialization plan, calling for action", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-46a1-7225-9b14-04fe7f7f59d9", "docSlug": "2120122995ea0e3bcae2e5ba1ee4dadc", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 23 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "go_to_market", "function": "plan_implementation", "notes": "Includes a map of the US and Europe with color-coded status indicators.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-46a1-7225-9b14-04fe7f7f59d9/12", "deckHref": "/decks/019de071-46a1-7225-9b14-04fe7f7f59d9", "deckAnchorHref": "/decks/019de071-46a1-7225-9b14-04fe7f7f59d9#slide-12", "loopMatches": [ { "to": 12, "from": 10, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "81ffe8fb-6e04-4bb2-b668-9b0f1dd6692c", "evidence": "Slides 10-12 present the go-to-market strategy and commercialization plan, highlighting quick wins and big bets", "position": 1, "objective": "What are the quick wins and big bets for ColoAlert's commercialization?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 12, "from": 10, "beatId": "b6ce095a-2569-4613-b6ea-05637d9e9e17", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Action", "beatSlug": "monroes-sequence-action", "evidence": "Slides 10-12 present the go-to-market strategy and commercialization plan, calling for action", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-46a1-7225-9b14-04fe7f7f59d9", "docSlug": "2120122995ea0e3bcae2e5ba1ee4dadc", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 23 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "Includes a stock market snapshot of Exact Sciences and a clinical performance comparison table.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-46a1-7225-9b14-04fe7f7f59d9/13", "deckHref": "/decks/019de071-46a1-7225-9b14-04fe7f7f59d9", "deckAnchorHref": "/decks/019de071-46a1-7225-9b14-04fe7f7f59d9#slide-13", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-46a1-7225-9b14-04fe7f7f59d9", "docSlug": "2120122995ea0e3bcae2e5ba1ee4dadc", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 23 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "market_sizing", "function": "size_opportunity", "notes": "Includes a disclaimer at the bottom and a product visualization.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-46a1-7225-9b14-04fe7f7f59d9/14", "deckHref": "/decks/019de071-46a1-7225-9b14-04fe7f7f59d9", "deckAnchorHref": "/decks/019de071-46a1-7225-9b14-04fe7f7f59d9#slide-14", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-46a1-7225-9b14-04fe7f7f59d9", "docSlug": "2120122995ea0e3bcae2e5ba1ee4dadc", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 23 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "context", "function": "establish_context", "notes": "Includes a photo of the office building and a grid of partner/affiliate logos.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-46a1-7225-9b14-04fe7f7f59d9/15", "deckHref": "/decks/019de071-46a1-7225-9b14-04fe7f7f59d9", "deckAnchorHref": "/decks/019de071-46a1-7225-9b14-04fe7f7f59d9#slide-15", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-46a1-7225-9b14-04fe7f7f59d9", "docSlug": "2120122995ea0e3bcae2e5ba1ee4dadc", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 23 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "team_bio", "function": "other", "notes": "The slide lists four key executives: CEO, CFO, COO, and CSO.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-46a1-7225-9b14-04fe7f7f59d9/16", "deckHref": "/decks/019de071-46a1-7225-9b14-04fe7f7f59d9", "deckAnchorHref": "/decks/019de071-46a1-7225-9b14-04fe7f7f59d9#slide-16", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-46a1-7225-9b14-04fe7f7f59d9", "docSlug": "2120122995ea0e3bcae2e5ba1ee4dadc", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 23 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "team_bio", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-46a1-7225-9b14-04fe7f7f59d9/17", "deckHref": "/decks/019de071-46a1-7225-9b14-04fe7f7f59d9", "deckAnchorHref": "/decks/019de071-46a1-7225-9b14-04fe7f7f59d9#slide-17", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-46a1-7225-9b14-04fe7f7f59d9", "docSlug": "2120122995ea0e3bcae2e5ba1ee4dadc", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 23 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "executive_summary", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-46a1-7225-9b14-04fe7f7f59d9/18", "deckHref": "/decks/019de071-46a1-7225-9b14-04fe7f7f59d9", "deckAnchorHref": "/decks/019de071-46a1-7225-9b14-04fe7f7f59d9#slide-18", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-46a1-7225-9b14-04fe7f7f59d9", "docSlug": "2120122995ea0e3bcae2e5ba1ee4dadc", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 23 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "closing_ask", "function": "state_next_steps", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-46a1-7225-9b14-04fe7f7f59d9/19", "deckHref": "/decks/019de071-46a1-7225-9b14-04fe7f7f59d9", "deckAnchorHref": "/decks/019de071-46a1-7225-9b14-04fe7f7f59d9#slide-19", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-46a1-7225-9b14-04fe7f7f59d9", "docSlug": "2120122995ea0e3bcae2e5ba1ee4dadc", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 23 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "appendix", "function": "appendix", "notes": "The slide serves as a repository for additional information, specifically partner logos and team representation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-46a1-7225-9b14-04fe7f7f59d9/20", "deckHref": "/decks/019de071-46a1-7225-9b14-04fe7f7f59d9", "deckAnchorHref": "/decks/019de071-46a1-7225-9b14-04fe7f7f59d9#slide-20", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-46a1-7225-9b14-04fe7f7f59d9", "docSlug": "2120122995ea0e3bcae2e5ba1ee4dadc", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 23 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "product_demo", "function": "present_solution", "notes": "Includes a disclaimer at the bottom and a citation for the 85% detection rate.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-46a1-7225-9b14-04fe7f7f59d9/21", "deckHref": "/decks/019de071-46a1-7225-9b14-04fe7f7f59d9", "deckAnchorHref": "/decks/019de071-46a1-7225-9b14-04fe7f7f59d9#slide-21", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-46a1-7225-9b14-04fe7f7f59d9", "docSlug": "2120122995ea0e3bcae2e5ba1ee4dadc", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 23 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "other", "function": "establish_context", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-46a1-7225-9b14-04fe7f7f59d9/22", "deckHref": "/decks/019de071-46a1-7225-9b14-04fe7f7f59d9", "deckAnchorHref": "/decks/019de071-46a1-7225-9b14-04fe7f7f59d9#slide-22", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-46a1-7225-9b14-04fe7f7f59d9", "docSlug": "2120122995ea0e3bcae2e5ba1ee4dadc", "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 23 slides", "authorId": "mainz-biomed-nv", "authorName": "Mainz Biomed", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide includes a specific milestone criterion for February 2022 regarding biomarker specificity.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-46a1-7225-9b14-04fe7f7f59d9/23", "deckHref": "/decks/019de071-46a1-7225-9b14-04fe7f7f59d9", "deckAnchorHref": "/decks/019de071-46a1-7225-9b14-04fe7f7f59d9#slide-23", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-473e-712d-87f0-b99471a2308d", "docSlug": "b8bc6e04b9c70160cc1bc532a2ac4eea", "documentTitle": "Nuvalent | IPO Presentation Deck | 40 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7827299, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": "Features a molecular structure visualization.", "imagePath": "https://imgproxy.kitesheet.com/50ilxjC272eHbqIuMy4i9ABJZz_n885KiREEAIKz4a4/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9iOGJjNmUwNGI5YzcwMTYwY2MxYmM1MzJhMmFjNGVlYS9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-473e-712d-87f0-b99471a2308d/1", "deckHref": "/decks/019de071-473e-712d-87f0-b99471a2308d", "deckAnchorHref": "/decks/019de071-473e-712d-87f0-b99471a2308d#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/9xHBEIOZbCDh-g3RnjGJLBdm-QJMXygbN_zAHXzKWA8/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9iOGJjNmUwNGI5YzcwMTYwY2MxYmM1MzJhMmFjNGVlYS9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/ipfFJhNSBb9LYYIaaZ_3HoeRtnzxdPwzfUMrad8m6Mk/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9iOGJjNmUwNGI5YzcwMTYwY2MxYmM1MzJhMmFjNGVlYS9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/XNN2oIn8dyo5ixLjzSS7aYs6jHZmFgAr-AuK2_idrXw/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9iOGJjNmUwNGI5YzcwMTYwY2MxYmM1MzJhMmFjNGVlYS9wMDAxLnBuZw" }, { "docId": "019de071-473e-712d-87f0-b99471a2308d", "docSlug": "b8bc6e04b9c70160cc1bc532a2ac4eea", "documentTitle": "Nuvalent | IPO Presentation Deck | 40 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7827299, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-473e-712d-87f0-b99471a2308d/2", "deckHref": "/decks/019de071-473e-712d-87f0-b99471a2308d", "deckAnchorHref": "/decks/019de071-473e-712d-87f0-b99471a2308d#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-473e-712d-87f0-b99471a2308d", "docSlug": "b8bc6e04b9c70160cc1bc532a2ac4eea", "documentTitle": "Nuvalent | IPO Presentation Deck | 40 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7827299, "pageNumber": 3, "slideType": "use_of_funds", "function": "plan_implementation", "notes": "This is a standard IPO deal term sheet slide.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-473e-712d-87f0-b99471a2308d/3", "deckHref": "/decks/019de071-473e-712d-87f0-b99471a2308d", "deckAnchorHref": "/decks/019de071-473e-712d-87f0-b99471a2308d#slide-3", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-473e-712d-87f0-b99471a2308d", "docSlug": "b8bc6e04b9c70160cc1bc532a2ac4eea", "documentTitle": "Nuvalent | IPO Presentation Deck | 40 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7827299, "pageNumber": 4, "slideType": "traction", "function": "show_traction", "notes": "The slide combines a funding timeline on the left with a strategic summary on the right.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-473e-712d-87f0-b99471a2308d/4", "deckHref": "/decks/019de071-473e-712d-87f0-b99471a2308d", "deckAnchorHref": "/decks/019de071-473e-712d-87f0-b99471a2308d#slide-4", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-473e-712d-87f0-b99471a2308d", "docSlug": "b8bc6e04b9c70160cc1bc532a2ac4eea", "documentTitle": "Nuvalent | IPO Presentation Deck | 40 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7827299, "pageNumber": 5, "slideType": "solution", "function": "present_solution", "notes": "Uses a Venn diagram to illustrate the intersection of two critical clinical challenges.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-473e-712d-87f0-b99471a2308d/5", "deckHref": "/decks/019de071-473e-712d-87f0-b99471a2308d", "deckAnchorHref": "/decks/019de071-473e-712d-87f0-b99471a2308d#slide-5", "loopMatches": [], "arcBeatMatches": [ { "to": 5, "from": 5, "beatId": "e4c5f6d4-a670-42b1-a2dd-ce13345e56bb", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Solution", "beatSlug": "sequoia-pitch-solution", "evidence": "The document presents Nuvalent's precisely targeted therapies as a solution to the problem.", "position": 1, "confidence": 0.8, "parentBeatName": "Turn", "parentBeatSlug": "turn" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-473e-712d-87f0-b99471a2308d", "docSlug": "b8bc6e04b9c70160cc1bc532a2ac4eea", "documentTitle": "Nuvalent | IPO Presentation Deck | 40 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7827299, "pageNumber": 6, "slideType": "problem_statement", "function": "frame_problem", "notes": "Uses a before-after-bridge framework to contrast existing therapy failure with Nuvalent's solution.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-473e-712d-87f0-b99471a2308d/6", "deckHref": "/decks/019de071-473e-712d-87f0-b99471a2308d", "deckAnchorHref": "/decks/019de071-473e-712d-87f0-b99471a2308d#slide-6", "loopMatches": [], "arcBeatMatches": [ { "to": 7, "from": 6, "beatId": "71a3542f-5e19-48ff-9928-ffb95d721df1", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The document presents the problem of kinase resistance and selectivity issues in cancer treatment.", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-473e-712d-87f0-b99471a2308d", "docSlug": "b8bc6e04b9c70160cc1bc532a2ac4eea", "documentTitle": "Nuvalent | IPO Presentation Deck | 40 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7827299, "pageNumber": 7, "slideType": "solution", "function": "present_solution", "notes": "Uses a visual comparison diagram to explain the mechanism of action and clinical benefit of selectivity.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-473e-712d-87f0-b99471a2308d/7", "deckHref": "/decks/019de071-473e-712d-87f0-b99471a2308d", "deckAnchorHref": "/decks/019de071-473e-712d-87f0-b99471a2308d#slide-7", "loopMatches": [], "arcBeatMatches": [ { "to": 7, "from": 6, "beatId": "71a3542f-5e19-48ff-9928-ffb95d721df1", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Problem", "beatSlug": "sequoia-pitch-problem", "evidence": "The document presents the problem of kinase resistance and selectivity issues in cancer treatment.", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-473e-712d-87f0-b99471a2308d", "docSlug": "b8bc6e04b9c70160cc1bc532a2ac4eea", "documentTitle": "Nuvalent | IPO Presentation Deck | 40 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7827299, "pageNumber": 8, "slideType": "roadmap", "function": "plan_implementation", "notes": "The chart uses a Gantt-style visualization to show progress from discovery through IND enabling phases.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-473e-712d-87f0-b99471a2308d/8", "deckHref": "/decks/019de071-473e-712d-87f0-b99471a2308d", "deckAnchorHref": "/decks/019de071-473e-712d-87f0-b99471a2308d#slide-8", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-473e-712d-87f0-b99471a2308d", "docSlug": "b8bc6e04b9c70160cc1bc532a2ac4eea", "documentTitle": "Nuvalent | IPO Presentation Deck | 40 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7827299, "pageNumber": 9, "slideType": "team_bio", "function": "other", "notes": "Includes a section on 'Prior FDA Approval Experience' with company logos.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-473e-712d-87f0-b99471a2308d/9", "deckHref": "/decks/019de071-473e-712d-87f0-b99471a2308d", "deckAnchorHref": "/decks/019de071-473e-712d-87f0-b99471a2308d#slide-9", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-473e-712d-87f0-b99471a2308d", "docSlug": "b8bc6e04b9c70160cc1bc532a2ac4eea", "documentTitle": "Nuvalent | IPO Presentation Deck | 40 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7827299, "pageNumber": 10, "slideType": "solution", "function": "present_solution", "notes": "The slide features a 3D molecular rendering showing the inhibitor (pink) bound to the target protein (blue).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-473e-712d-87f0-b99471a2308d/10", "deckHref": "/decks/019de071-473e-712d-87f0-b99471a2308d", "deckAnchorHref": "/decks/019de071-473e-712d-87f0-b99471a2308d#slide-10", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-473e-712d-87f0-b99471a2308d", "docSlug": "b8bc6e04b9c70160cc1bc532a2ac4eea", "documentTitle": "Nuvalent | IPO Presentation Deck | 40 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7827299, "pageNumber": 11, "slideType": "context", "function": "establish_context", "notes": "The slide uses a three-part process flow to explain the biological mechanism of ROS1-driven disease and resistance.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-473e-712d-87f0-b99471a2308d/11", "deckHref": "/decks/019de071-473e-712d-87f0-b99471a2308d", "deckAnchorHref": "/decks/019de071-473e-712d-87f0-b99471a2308d#slide-11", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-473e-712d-87f0-b99471a2308d", "docSlug": "b8bc6e04b9c70160cc1bc532a2ac4eea", "documentTitle": "Nuvalent | IPO Presentation Deck | 40 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7827299, "pageNumber": 12, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The table highlights the clinical limitations of current standard-of-care drugs (Crizotinib, Entrectinib) due to resistance mutations like G2032R and CNS involvement.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-473e-712d-87f0-b99471a2308d/12", "deckHref": "/decks/019de071-473e-712d-87f0-b99471a2308d", "deckAnchorHref": "/decks/019de071-473e-712d-87f0-b99471a2308d#slide-12", "loopMatches": [], "arcBeatMatches": [ { "to": 13, "from": 12, "beatId": "76bf6e65-e83b-45d8-b243-26284b3f78ae", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Sizing", "beatSlug": null, "evidence": "The document provides an overview of the ROS1-positive NSCLC market and the emerging resistance mutations and increasing CNS involvement.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-473e-712d-87f0-b99471a2308d", "docSlug": "b8bc6e04b9c70160cc1bc532a2ac4eea", "documentTitle": "Nuvalent | IPO Presentation Deck | 40 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7827299, "pageNumber": 13, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The table uses a green/white color coding to highlight the competitive advantage of NVL-520.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-473e-712d-87f0-b99471a2308d/13", "deckHref": "/decks/019de071-473e-712d-87f0-b99471a2308d", "deckAnchorHref": "/decks/019de071-473e-712d-87f0-b99471a2308d#slide-13", "loopMatches": [], "arcBeatMatches": [ { "to": 13, "from": 12, "beatId": "76bf6e65-e83b-45d8-b243-26284b3f78ae", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Market Sizing", "beatSlug": null, "evidence": "The document provides an overview of the ROS1-positive NSCLC market and the emerging resistance mutations and increasing CNS involvement.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null }, { "to": 14, "from": 13, "beatId": "9fc4031d-1f84-4f60-88cc-0072472dae1f", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Competition", "beatSlug": "sequoia-pitch-competition", "evidence": "The document presents a competitive analysis of Nuvalent's therapies.", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-473e-712d-87f0-b99471a2308d", "docSlug": "b8bc6e04b9c70160cc1bc532a2ac4eea", "documentTitle": "Nuvalent | IPO Presentation Deck | 40 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7827299, "pageNumber": 14, "slideType": "problem_statement", "function": "frame_problem", "notes": "The slide uses a medical illustration to map specific TRK receptor inhibition (TRKB, TRKC, TRKA) to corresponding neurological and physiological side effects.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-473e-712d-87f0-b99471a2308d/14", "deckHref": "/decks/019de071-473e-712d-87f0-b99471a2308d", "deckAnchorHref": "/decks/019de071-473e-712d-87f0-b99471a2308d#slide-14", "loopMatches": [], "arcBeatMatches": [ { "to": 14, "from": 13, "beatId": "9fc4031d-1f84-4f60-88cc-0072472dae1f", "arcName": "The Sequoia Pitch", "arcSlug": "sequoia-pitch", "beatName": "Competition", "beatSlug": "sequoia-pitch-competition", "evidence": "The document presents a competitive analysis of Nuvalent's therapies.", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-473e-712d-87f0-b99471a2308d", "docSlug": "b8bc6e04b9c70160cc1bc532a2ac4eea", "documentTitle": "Nuvalent | IPO Presentation Deck | 40 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7827299, "pageNumber": 15, "slideType": "product_demo", "function": "present_solution", "notes": "The slide uses a structured table-like layout to define the product profile.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-473e-712d-87f0-b99471a2308d/15", "deckHref": "/decks/019de071-473e-712d-87f0-b99471a2308d", "deckAnchorHref": "/decks/019de071-473e-712d-87f0-b99471a2308d#slide-15", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-473e-712d-87f0-b99471a2308d", "docSlug": "b8bc6e04b9c70160cc1bc532a2ac4eea", "documentTitle": "Nuvalent | IPO Presentation Deck | 40 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7827299, "pageNumber": 16, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes a table of IC50 values and a line chart showing tumor volume over time for different dosages.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-473e-712d-87f0-b99471a2308d/16", "deckHref": "/decks/019de071-473e-712d-87f0-b99471a2308d", "deckAnchorHref": "/decks/019de071-473e-712d-87f0-b99471a2308d#slide-16", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-473e-712d-87f0-b99471a2308d", "docSlug": "b8bc6e04b9c70160cc1bc532a2ac4eea", "documentTitle": "Nuvalent | IPO Presentation Deck | 40 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7827299, "pageNumber": 17, "slideType": "solution", "function": "present_solution", "notes": "Includes a heatmap table for IC50 values and two line charts showing tumor volume reduction in PDX models.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-473e-712d-87f0-b99471a2308d/17", "deckHref": "/decks/019de071-473e-712d-87f0-b99471a2308d", "deckAnchorHref": "/decks/019de071-473e-712d-87f0-b99471a2308d#slide-17", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-473e-712d-87f0-b99471a2308d", "docSlug": "b8bc6e04b9c70160cc1bc532a2ac4eea", "documentTitle": "Nuvalent | IPO Presentation Deck | 40 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7827299, "pageNumber": 18, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The chart uses a logarithmic scale to show relative selectivity ratios.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-473e-712d-87f0-b99471a2308d/18", "deckHref": "/decks/019de071-473e-712d-87f0-b99471a2308d", "deckAnchorHref": "/decks/019de071-473e-712d-87f0-b99471a2308d#slide-18", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-473e-712d-87f0-b99471a2308d", "docSlug": "b8bc6e04b9c70160cc1bc532a2ac4eea", "documentTitle": "Nuvalent | IPO Presentation Deck | 40 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7827299, "pageNumber": 19, "slideType": "solution", "function": "present_solution", "notes": "The kinome tree is a standard visualization in pharmacology for kinase selectivity.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-473e-712d-87f0-b99471a2308d/19", "deckHref": "/decks/019de071-473e-712d-87f0-b99471a2308d", "deckAnchorHref": "/decks/019de071-473e-712d-87f0-b99471a2308d#slide-19", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-473e-712d-87f0-b99471a2308d", "docSlug": "b8bc6e04b9c70160cc1bc532a2ac4eea", "documentTitle": "Nuvalent | IPO Presentation Deck | 40 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7827299, "pageNumber": 20, "slideType": "solution", "function": "present_solution", "notes": "The slide highlights CNS activity via brain penetration, a key component of the NVL-520 target product profile.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-473e-712d-87f0-b99471a2308d/20", "deckHref": "/decks/019de071-473e-712d-87f0-b99471a2308d", "deckAnchorHref": "/decks/019de071-473e-712d-87f0-b99471a2308d#slide-20", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-473e-712d-87f0-b99471a2308d", "docSlug": "b8bc6e04b9c70160cc1bc532a2ac4eea", "documentTitle": "Nuvalent | IPO Presentation Deck | 40 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7827299, "pageNumber": 21, "slideType": "traction", "function": "show_traction", "notes": "The slide uses bioluminescence imaging to show tumor reduction and a Kaplan-Meier survival curve to show efficacy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-473e-712d-87f0-b99471a2308d/21", "deckHref": "/decks/019de071-473e-712d-87f0-b99471a2308d", "deckAnchorHref": "/decks/019de071-473e-712d-87f0-b99471a2308d#slide-21", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-473e-712d-87f0-b99471a2308d", "docSlug": "b8bc6e04b9c70160cc1bc532a2ac4eea", "documentTitle": "Nuvalent | IPO Presentation Deck | 40 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7827299, "pageNumber": 22, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide lists specific key opinion leaders (KOLs) and their respective institutions across the US, Spain, France, and the Netherlands.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-473e-712d-87f0-b99471a2308d/22", "deckHref": "/decks/019de071-473e-712d-87f0-b99471a2308d", "deckAnchorHref": "/decks/019de071-473e-712d-87f0-b99471a2308d#slide-22", "loopMatches": [ { "to": 23, "from": 22, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "eb06e03e-4835-4d57-9906-4c725d518b80", "evidence": "The document presents the planned clinical trial as a significant milestone.", "position": 1, "objective": "Present the planned NVL-520 first-in-human clinical trial", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.7, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-473e-712d-87f0-b99471a2308d", "docSlug": "b8bc6e04b9c70160cc1bc532a2ac4eea", "documentTitle": "Nuvalent | IPO Presentation Deck | 40 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7827299, "pageNumber": 23, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a hybrid layout combining a staircase diagram for Phase 1 and a structured table for Phase 2.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-473e-712d-87f0-b99471a2308d/23", "deckHref": "/decks/019de071-473e-712d-87f0-b99471a2308d", "deckAnchorHref": "/decks/019de071-473e-712d-87f0-b99471a2308d#slide-23", "loopMatches": [ { "to": 23, "from": 22, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "eb06e03e-4835-4d57-9906-4c725d518b80", "evidence": "The document presents the planned clinical trial as a significant milestone.", "position": 1, "objective": "Present the planned NVL-520 first-in-human clinical trial", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.7, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-473e-712d-87f0-b99471a2308d", "docSlug": "b8bc6e04b9c70160cc1bc532a2ac4eea", "documentTitle": "Nuvalent | IPO Presentation Deck | 40 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7827299, "pageNumber": 24, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a high-quality 3D molecular rendering to illustrate the mechanism of action.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-473e-712d-87f0-b99471a2308d/24", "deckHref": "/decks/019de071-473e-712d-87f0-b99471a2308d", "deckAnchorHref": "/decks/019de071-473e-712d-87f0-b99471a2308d#slide-24", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-473e-712d-87f0-b99471a2308d", "docSlug": "b8bc6e04b9c70160cc1bc532a2ac4eea", "documentTitle": "Nuvalent | IPO Presentation Deck | 40 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7827299, "pageNumber": 25, "slideType": "context", "function": "establish_context", "notes": "The slide uses a three-column process flow to explain the biological mechanism of ALK-driven cancer and resistance.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-473e-712d-87f0-b99471a2308d/25", "deckHref": "/decks/019de071-473e-712d-87f0-b99471a2308d", "deckAnchorHref": "/decks/019de071-473e-712d-87f0-b99471a2308d#slide-25", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-473e-712d-87f0-b99471a2308d", "docSlug": "b8bc6e04b9c70160cc1bc532a2ac4eea", "documentTitle": "Nuvalent | IPO Presentation Deck | 40 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7827299, "pageNumber": 26, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The slide highlights the clinical unmet need as patients progress through lines of therapy, specifically noting resistance mutations and CNS involvement.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-473e-712d-87f0-b99471a2308d/26", "deckHref": "/decks/019de071-473e-712d-87f0-b99471a2308d", "deckAnchorHref": "/decks/019de071-473e-712d-87f0-b99471a2308d#slide-26", "loopMatches": [ { "to": 27, "from": 26, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "4b8e9c07-9cc9-4c6f-ad54-bd0e47584001", "evidence": "The document presents the limitations of current treatments and the need for new solutions.", "position": 0, "objective": "Highlight the limitations of current treatments and the need for new solutions", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-473e-712d-87f0-b99471a2308d", "docSlug": "b8bc6e04b9c70160cc1bc532a2ac4eea", "documentTitle": "Nuvalent | IPO Presentation Deck | 40 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7827299, "pageNumber": 27, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The table uses a green/white color coding to highlight the superior profile of NVL-655 compared to existing therapies.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-473e-712d-87f0-b99471a2308d/27", "deckHref": "/decks/019de071-473e-712d-87f0-b99471a2308d", "deckAnchorHref": "/decks/019de071-473e-712d-87f0-b99471a2308d#slide-27", "loopMatches": [ { "to": 27, "from": 26, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "4b8e9c07-9cc9-4c6f-ad54-bd0e47584001", "evidence": "The document presents the limitations of current treatments and the need for new solutions.", "position": 0, "objective": "Highlight the limitations of current treatments and the need for new solutions", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-473e-712d-87f0-b99471a2308d", "docSlug": "b8bc6e04b9c70160cc1bc532a2ac4eea", "documentTitle": "Nuvalent | IPO Presentation Deck | 40 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7827299, "pageNumber": 28, "slideType": "product_demo", "function": "present_solution", "notes": "The slide uses a structured table format to define the product's key performance characteristics.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-473e-712d-87f0-b99471a2308d/28", "deckHref": "/decks/019de071-473e-712d-87f0-b99471a2308d", "deckAnchorHref": "/decks/019de071-473e-712d-87f0-b99471a2308d#slide-28", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-473e-712d-87f0-b99471a2308d", "docSlug": "b8bc6e04b9c70160cc1bc532a2ac4eea", "documentTitle": "Nuvalent | IPO Presentation Deck | 40 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7827299, "pageNumber": 29, "slideType": "appendix_data", "function": "analyze_data", "notes": "The slide uses a color-coded heatmap to indicate potency (green for high potency, yellow for lower).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-473e-712d-87f0-b99471a2308d/29", "deckHref": "/decks/019de071-473e-712d-87f0-b99471a2308d", "deckAnchorHref": "/decks/019de071-473e-712d-87f0-b99471a2308d#slide-29", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-473e-712d-87f0-b99471a2308d", "docSlug": "b8bc6e04b9c70160cc1bc532a2ac4eea", "documentTitle": "Nuvalent | IPO Presentation Deck | 40 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7827299, "pageNumber": 30, "slideType": "appendix_data", "function": "analyze_data", "notes": "Includes a table of IC50 values and two line charts showing tumor volume reduction in CDX models.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-473e-712d-87f0-b99471a2308d/30", "deckHref": "/decks/019de071-473e-712d-87f0-b99471a2308d", "deckAnchorHref": "/decks/019de071-473e-712d-87f0-b99471a2308d#slide-30", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-473e-712d-87f0-b99471a2308d", "docSlug": "b8bc6e04b9c70160cc1bc532a2ac4eea", "documentTitle": "Nuvalent | IPO Presentation Deck | 40 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7827299, "pageNumber": 31, "slideType": "competitive_analysis", "function": "compare_peers", "notes": "The chart uses a logarithmic scale to show fold-selectivity. NVL-655 shows significantly higher selectivity for ALK variants compared to the other two drugs.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-473e-712d-87f0-b99471a2308d/31", "deckHref": "/decks/019de071-473e-712d-87f0-b99471a2308d", "deckAnchorHref": "/decks/019de071-473e-712d-87f0-b99471a2308d#slide-31", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-473e-712d-87f0-b99471a2308d", "docSlug": "b8bc6e04b9c70160cc1bc532a2ac4eea", "documentTitle": "Nuvalent | IPO Presentation Deck | 40 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7827299, "pageNumber": 32, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a kinome tree diagram to visualize selectivity. The table defines the selectivity index based on IC50 ratios.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-473e-712d-87f0-b99471a2308d/32", "deckHref": "/decks/019de071-473e-712d-87f0-b99471a2308d", "deckAnchorHref": "/decks/019de071-473e-712d-87f0-b99471a2308d#slide-32", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-473e-712d-87f0-b99471a2308d", "docSlug": "b8bc6e04b9c70160cc1bc532a2ac4eea", "documentTitle": "Nuvalent | IPO Presentation Deck | 40 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7827299, "pageNumber": 33, "slideType": "traction", "function": "analyze_data", "notes": "Includes disclaimer regarding clinical studies and FDA feedback.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-473e-712d-87f0-b99471a2308d/33", "deckHref": "/decks/019de071-473e-712d-87f0-b99471a2308d", "deckAnchorHref": "/decks/019de071-473e-712d-87f0-b99471a2308d#slide-33", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-473e-712d-87f0-b99471a2308d", "docSlug": "b8bc6e04b9c70160cc1bc532a2ac4eea", "documentTitle": "Nuvalent | IPO Presentation Deck | 40 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7827299, "pageNumber": 34, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-473e-712d-87f0-b99471a2308d/34", "deckHref": "/decks/019de071-473e-712d-87f0-b99471a2308d", "deckAnchorHref": "/decks/019de071-473e-712d-87f0-b99471a2308d#slide-34", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-473e-712d-87f0-b99471a2308d", "docSlug": "b8bc6e04b9c70160cc1bc532a2ac4eea", "documentTitle": "Nuvalent | IPO Presentation Deck | 40 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7827299, "pageNumber": 35, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a hexagonal process flow diagram to illustrate the three-step methodology.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-473e-712d-87f0-b99471a2308d/35", "deckHref": "/decks/019de071-473e-712d-87f0-b99471a2308d", "deckAnchorHref": "/decks/019de071-473e-712d-87f0-b99471a2308d#slide-35", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-473e-712d-87f0-b99471a2308d", "docSlug": "b8bc6e04b9c70160cc1bc532a2ac4eea", "documentTitle": "Nuvalent | IPO Presentation Deck | 40 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7827299, "pageNumber": 36, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a side-by-side comparison structure to highlight the target product profiles for ALK IXDN Resistance Mutations and HER2 Exon 20 Insertions.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-473e-712d-87f0-b99471a2308d/36", "deckHref": "/decks/019de071-473e-712d-87f0-b99471a2308d", "deckAnchorHref": "/decks/019de071-473e-712d-87f0-b99471a2308d#slide-36", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-473e-712d-87f0-b99471a2308d", "docSlug": "b8bc6e04b9c70160cc1bc532a2ac4eea", "documentTitle": "Nuvalent | IPO Presentation Deck | 40 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7827299, "pageNumber": 37, "slideType": "roadmap", "function": "plan_implementation", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-473e-712d-87f0-b99471a2308d/37", "deckHref": "/decks/019de071-473e-712d-87f0-b99471a2308d", "deckAnchorHref": "/decks/019de071-473e-712d-87f0-b99471a2308d#slide-37", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-473e-712d-87f0-b99471a2308d", "docSlug": "b8bc6e04b9c70160cc1bc532a2ac4eea", "documentTitle": "Nuvalent | IPO Presentation Deck | 40 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7827299, "pageNumber": 38, "slideType": "timeline", "function": "show_traction", "notes": "The slide uses a dual-track timeline: top for corporate events, bottom for clinical/R&D pipeline progress.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-473e-712d-87f0-b99471a2308d/38", "deckHref": "/decks/019de071-473e-712d-87f0-b99471a2308d", "deckAnchorHref": "/decks/019de071-473e-712d-87f0-b99471a2308d#slide-38", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-473e-712d-87f0-b99471a2308d", "docSlug": "b8bc6e04b9c70160cc1bc532a2ac4eea", "documentTitle": "Nuvalent | IPO Presentation Deck | 40 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7827299, "pageNumber": 39, "slideType": "solution", "function": "present_solution", "notes": "The slide features a 3D molecular structure visualization, likely a protein-ligand complex.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-473e-712d-87f0-b99471a2308d/39", "deckHref": "/decks/019de071-473e-712d-87f0-b99471a2308d", "deckAnchorHref": "/decks/019de071-473e-712d-87f0-b99471a2308d#slide-39", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-473e-712d-87f0-b99471a2308d", "docSlug": "b8bc6e04b9c70160cc1bc532a2ac4eea", "documentTitle": "Nuvalent | IPO Presentation Deck | 40 slides", "authorId": "nuvalent", "authorName": "Nuvalent", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7827299, "pageNumber": 40, "slideType": "cover", "function": "front_matter", "notes": "Features company logo and a molecular structure visualization.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-473e-712d-87f0-b99471a2308d/40", "deckHref": "/decks/019de071-473e-712d-87f0-b99471a2308d", "deckAnchorHref": "/decks/019de071-473e-712d-87f0-b99471a2308d#slide-40", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4830-7608-84e8-b3f03659010d", "docSlug": "f2adf3cca406f89f9f21532698bebce4", "documentTitle": "Omega Therapeutics | IPO Presentation Deck | 33 slides", "authorId": "omega-therapeutics", "authorName": "Omega Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7843866, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/eQ9WUwifr7ACA9NRa1ODeqBCuw9OTZYfRnrx99DbHz0/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9mMmFkZjNjY2E0MDZmODlmOWYyMTUzMjY5OGJlYmNlNC9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4830-7608-84e8-b3f03659010d/1", "deckHref": "/decks/019de071-4830-7608-84e8-b3f03659010d", "deckAnchorHref": "/decks/019de071-4830-7608-84e8-b3f03659010d#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/qWLnFL1UphHjy43zHRpEIa62fdhrNAovXpsWLzkrwjQ/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9mMmFkZjNjY2E0MDZmODlmOWYyMTUzMjY5OGJlYmNlNC9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/wSc1ub_LW2MfjMo_CbMxthBaPspZqgPG9ae2NDu9rwo/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9mMmFkZjNjY2E0MDZmODlmOWYyMTUzMjY5OGJlYmNlNC9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/L9vG4LQ-yQwso_MoM-zr5ZKMP8FUizP0877N-Y-hjaw/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9mMmFkZjNjY2E0MDZmODlmOWYyMTUzMjY5OGJlYmNlNC9wMDAxLnBuZw" }, { "docId": "019de071-4830-7608-84e8-b3f03659010d", "docSlug": "f2adf3cca406f89f9f21532698bebce4", "documentTitle": "Omega Therapeutics | IPO Presentation Deck | 33 slides", "authorId": "omega-therapeutics", "authorName": "Omega Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7843866, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4830-7608-84e8-b3f03659010d/2", "deckHref": "/decks/019de071-4830-7608-84e8-b3f03659010d", "deckAnchorHref": "/decks/019de071-4830-7608-84e8-b3f03659010d#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4830-7608-84e8-b3f03659010d", "docSlug": "f2adf3cca406f89f9f21532698bebce4", "documentTitle": "Omega Therapeutics | IPO Presentation Deck | 33 slides", "authorId": "omega-therapeutics", "authorName": "Omega Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7843866, "pageNumber": 3, "slideType": "appendix_data", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4830-7608-84e8-b3f03659010d/3", "deckHref": "/decks/019de071-4830-7608-84e8-b3f03659010d", "deckAnchorHref": "/decks/019de071-4830-7608-84e8-b3f03659010d#slide-3", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4830-7608-84e8-b3f03659010d", "docSlug": "f2adf3cca406f89f9f21532698bebce4", "documentTitle": "Omega Therapeutics | IPO Presentation Deck | 33 slides", "authorId": "omega-therapeutics", "authorName": "Omega Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7843866, "pageNumber": 4, "slideType": "mission", "function": "inspire_vision", "notes": "Uses a 'What if' rhetorical device to frame the company's core technological thesis.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4830-7608-84e8-b3f03659010d/4", "deckHref": "/decks/019de071-4830-7608-84e8-b3f03659010d", "deckAnchorHref": "/decks/019de071-4830-7608-84e8-b3f03659010d#slide-4", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4830-7608-84e8-b3f03659010d", "docSlug": "f2adf3cca406f89f9f21532698bebce4", "documentTitle": "Omega Therapeutics | IPO Presentation Deck | 33 slides", "authorId": "omega-therapeutics", "authorName": "Omega Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7843866, "pageNumber": 5, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a hub-and-spoke diagram to illustrate MYC's regulatory reach and a line chart to show efficacy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4830-7608-84e8-b3f03659010d/5", "deckHref": "/decks/019de071-4830-7608-84e8-b3f03659010d", "deckAnchorHref": "/decks/019de071-4830-7608-84e8-b3f03659010d#slide-5", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-4830-7608-84e8-b3f03659010d", "docSlug": "f2adf3cca406f89f9f21532698bebce4", "documentTitle": "Omega Therapeutics | IPO Presentation Deck | 33 slides", "authorId": "omega-therapeutics", "authorName": "Omega Therapeutics", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investment_bank", "sourceTypeLabel": "Investment bank", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7843866, "pageNumber": 6, "slideType": "solution", "function": "present_solution", "notes": "Uses a biological analogy of an 'operating system' to explain gene regulation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-4830-7608-84e8-b3f03659010d/6", "deckHref": "/decks/019de071-4830-7608-84e8-b3f03659010d", "deckAnchorHref": "/decks/019de071-4830-7608-84e8-b3f03659010d#slide-6", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }